WHO ICTRP trial
Effectiveness of Mifepristone and Letrozole in medical termination of pregnancy.
CTRI/2024/07/070965 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2024/07/070965 |
|---|---|
| Public title | Effectiveness of Mifepristone and Letrozole in medical termination of pregnancy. |
| Scientific title | Comparison between Letrozole and Mifepristone as pre-treatment in medical management of early pregnancy termination: a prospective open-label randomized controlled trial. - NIL |
| Primary sponsor | Sanchari Debnath |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: O00-O08- Pregnancy with abortive outcome |
| Interventions | Intervention1: Letrozole: Tablet Letrozole will be given 10 mg once daily per orally for 3 days followed by Tab Misoprostol 800 mcg per vaginally on Day 3 Control Intervention1: Mifepristone: Tab Mifepristone will given 200 mg once stat… |
| Registration date | Jul 22, 2024 |
| Target size | 160 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: